Home › Funds › OFI INVEST ASSET MANAGEMENT › ABBV

OFI INVEST ASSET MANAGEMENT position in ABBV

Abbvie Inc · Health Care

OFI INVEST ASSET MANAGEMENT reported holding 261,001 shares of ABBV (Abbvie Inc) in its Q3 2026 13F filing — a position valued at US$60.5M, representing 0.61% of its reported portfolio and ranking #34 among its reported holdings. OFI INVEST ASSET MANAGEMENT has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)261.00K sh
Reported value held$60.52M
Portfolio Weight0.61%
First reportedQ3 2023
Last changeReduce
Updated2026-11-06

Last updated: 2026-11-06 · Source: SEC EDGAR Form 13F-HR

How OFI INVEST ASSET MANAGEMENT's ABBV position evolved

OFI INVEST ASSET MANAGEMENT first disclosed a stake in ABBV in Q3 2023 at 1,189 shares (US$167K). The position peaked in Q2 2026 at 274,288 shares, worth US$60.8M. Across 11 filings, OFI INVEST ASSET MANAGEMENT increased the stake 4 time(s), trimmed it 4 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 261,001 shares valued at US$60.5M — a reduction of -13,287 shares quarter over quarter.. Notable position changes include a 688% increase in Q4 2024 (shares rose 19% over the following quarter), a 1796% increase in Q2 2025 (shares rose 26% over the following quarter), a 73% increase in Q3 2025 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 1.19K $167.40K New
Q4 2023 1.19K $166.80K Hold
Q1 2024 1.19K $200.48K Hold
Q4 2024 9.38K $1.61M Add
Q1 2025 7.38K $1.43M Reduce
Q2 2025 140.04K $22.14M Add
Q3 2025 242.50K $47.79M Add
Q4 2025 278.99K $54.48M Add
Q1 2026 276.67K $52.54M Reduce
Q2 2026 274.29K $60.78M Reduce
Q3 2026 261.00K $60.52M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ABBV and 13F data

ABBV (Abbvie Inc) is a Health Care company. 35 other funds we track also report a position in ABBV — the largest reported positions include Vanguard Group (US$41.31B), BlackRock Inc (US$37.62B), VANGUARD CAPITAL MANAGEMENT LLC (US$29.04B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ABBV

All ABBV fund holders →

FAQ

How long has OFI INVEST ASSET MANAGEMENT held ABBV?

OFI INVEST ASSET MANAGEMENT has disclosed ABBV holdings in 11 of the last 13 reported quarters, going back to Q3 2023.

What is OFI INVEST ASSET MANAGEMENT's current position in ABBV?

As of Q3 2026, OFI INVEST ASSET MANAGEMENT holds 261.00K shares of ABBV (Abbvie Inc), valued at $60.52M, representing 0.61% of its reported portfolio and ranking #34.

Has OFI INVEST ASSET MANAGEMENT been buying or selling ABBV?

In the latest 13F filing (Q3 2026), OFI INVEST ASSET MANAGEMENT reduced its position in ABBV. The position peaked in Q2 2026 at 274.29K shares.

Which other funds hold ABBV?

Other major institutional holders of ABBV include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, among 35 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.